Neurocysticercosis among resettled refugees from Burma

Journal of Travel Medicine

Volumn 19, Issue 2, 2012, Pages 118-121

  O'Neal, Seth E ^a   Robbins, Nathaniel M ^b   Townes, John M ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MOUNT AUBURN HOSPITAL   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; CORTICOSTEROID; PRAZIQUANTEL;

ADULT; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HEADACHE; HOUSEHOLD; HUMAN; MYANMAR; NEMATODIASIS; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; REFUGEE; TAENIA SOLIUM; TAENIASIS; TONIC CLONIC SEIZURE;

ADRENAL CORTEX HORMONES; ADULT; ANIMALS; ANTICONVULSANTS; ANTIPARASITIC AGENTS; COMMUNICABLE DISEASE CONTROL; DIAGNOSIS, DIFFERENTIAL; DISEASE RESERVOIRS; EPILEPSY; FAMILY HEALTH; FEMALE; HEADACHE DISORDERS; HUMANS; MALE; MIDDLE AGED; MYANMAR; NEUROCYSTICERCOSIS; NEUROIMAGING; PRAZIQUANTEL; REFUGEES; SEIZURES; SEROLOGIC TESTS; TAENIA SOLIUM; UNITED STATES;

EID: 84858448839     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2011.00588.x     Document Type: Article

References (16)

1. Garcia HH, Del Brutto OH., Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005; 4: 653-661. (Pubitemid 41317300)
2. Rajshekhar V, Joshi DD, Doanh NQ, et al., Taenia solium taeniosis/cysticercosis in Asia: epidemiology, impact and issues. Acta Trop 2003; 87: 53-60. (Pubitemid 36637075)
3. Yeaney GA, Kolar BS, Silberstein HJ, Wang HZ., Case 163: solitary neurocysticercosis. Radiology 2010; 257: 581-585.
4. Hewagama SS, Darby JD, Sheorey H, Daffy JR., Seizures related to praziquantel therapy in neurocysticercosis. Med J Aust 2010; 193: 246-247.
5. Pluschke M, Bennett G., Orbital cysticercosis. Aust N Z J Ophthalmol 1998; 26: 333-336. (Pubitemid 28529900)
6. García HH, Evans CAW, Nash TE, et al., Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002; 15: 747-756. (Pubitemid 41184085)
7. Tsang VC, Brand JA, Boyer AE., An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989; 159: 50-59. (Pubitemid 19021995)
8. Garcia HH, Gonzalez AE, Gilman RH., Cysticercosis of the central nervous system: how should it be managed? Curr Opin Infect Dis 2011. Epub 2011 Jul 22.
9. Singhi P., Neurocysticercosis. Ther Adv Neurol Disord 2011; 4: 67-81.
10. Kruskal BA, Moths L, Teele DW., Neurocysticercosis in a child with no history of travel outside the continental United States. Clin Infect Dis 1993; 16: 290-2. (Pubitemid 23047432)
11. Asnis D, Kazakov J, Toronjadze T, et al., Neurocysticercosis in the infant of a pregnant mother with a tapeworm. Am J Trop Med Hyg 2009; 81: 449-451.
12. Schantz PM, Moore AC, Muñoz JL, et al., Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med 1992; 327: 692-695.
13. Garcia HH, Gonzalez I, Mija L., Neurocysticercosis uncovered by single-dose albendazole. N Engl J Med 2007; 356: 1277-1278.
14. Flisser A, Madrazo I, Plancarte A, et al., Neurological symptoms in occult neurocysticercosis after single taeniacidal dose of praziquantel. Lancet 1993; 342: 748. (Pubitemid 23279786)
15. Lillie P, McGann H., Empiric albendazole therapy and new onset seizures-a cautionary note. J Infect 2010; 60: 403-404.
16. Torres JR., Use of praziquantel in populations at risk of neurocysticercosis. Rev Inst Med Trop Sao Paulo 1989; 31: 290. (Pubitemid 19260285)